Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review
- PMID: 39456943
- PMCID: PMC11508361
- DOI: 10.3390/ijms252011163
Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review
Abstract
Migraine is a prevalent neurological disorder, particularly among individuals aged 20-50 years, with significant social and economic impacts. Despite its high prevalence, the pathogenesis of migraine remains unclear. In this review, we provide a comprehensive overview of cortical spreading depolarization/depression (CSD) and its close association with migraine aura, focusing on its role in understanding migraine pathogenesis and therapeutic interventions. We discuss historical studies that have demonstrated the role of CSD in the visual phenomenon of migraine aura, along with modern imaging techniques confirming its propagation across the occipital cortex. Animal studies are examined to indicate that CSD is not exclusive to migraines; it also occurs in other neurological conditions. At the cellular level, we review how CSD is characterized by ionic changes and excitotoxicity, leading to neuronal and glial responses. We explore how CSD activates the trigeminal nervous system and upregulates the expression of calcitonin gene-related peptides (CGRP), thereby contributing to migraine pain. Factors such as genetics, obesity, and environmental conditions that influence the CSD threshold are discussed, suggesting potential therapeutic targets. Current treatments for migraine, including prophylactic agents and CGRP-targeting drugs, are evaluated in the context of their expected effects on suppressing CSD activity. Additionally, we highlight emerging therapies such as intranasal insulin-like growth factor 1 and vagus nerve stimulation, which have shown promise in reducing CSD susceptibility and frequency. By elucidating the molecular and cellular mechanisms of CSD, this review aims to enhance the understanding of migraine pathogenesis and support the development of targeted therapeutic strategies.
Keywords: CGRP; CSD; intranasal insulin-like growth factor 1; migraine; trigeminal nervous system; vagus nerve stimulation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Steiner T.J., Stovner L.J., Jensen R., Uluduz D., Katsarava Z. Lifting the Burden: The Global Campaign against H. Migraine remains second among the world’s causes of disability, and first among young women: Findings from GBD2019. J. Headache Pain. 2020;21:137. doi: 10.1186/s10194-020-01208-0. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
